Chemed Target Price

Chemed (CHE) currently reports a target price of $650. Use the charts on this page to explore Chemed's target price history and peer comparisons.

Analysts' average 12-month price target for Chemed is $650, about 26.7% upside from the current share price of $512.98. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $650, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Chemed, and consider following CHE for alerts when major investors trade the stock.

Chemed is classified in the Healthcare sector. On target price, it currently shows $650. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CHE with unrelated industries.